http://www.guerbet.com/fr/en-rejoignant-guerbet-vous-choisissez-un-leader-mondial-taille-humaine 2021-07-29T11:09:11+02:00 0.5 http://www.guerbet.com/insights/when-you-join-guerbet-youve-chosen-human-scale-worldwide-leader 2021-07-29T11:09:11+02:00 0.5 http://www.guerbet.com/fr/lia-appliquee-aux-sciences-de-la-vie-au-dela-du-phenomene-de-mode 2021-07-29T11:09:18+02:00 0.5 http://www.guerbet.com/insights/ai-life-sciences-seeing-past-hype 2021-07-29T11:09:18+02:00 0.5 http://www.guerbet.com/fr/reduire-le-risque-quotidien-de-lembolisation-non-ciblee 2021-07-29T11:09:31+02:00 0.5 http://www.guerbet.com/insights/reducing-everyday-challenge-non-target-embolization 2021-07-29T11:09:31+02:00 0.5 http://www.guerbet.com/fr/guerbet-en-bonne-position-dans-le-gaia-index-2019-pour-la-2eme-annee-consecutive 2020-05-07T07:25:05+02:00 0.5 http://www.guerbet.com/news/guerbet-high-gaia-index-2nd-year-running 2020-05-07T07:25:05+02:00 0.5 http://www.guerbet.com/fr/actualites/chiffre-daffaires-au-30-septembre-2020 2025-08-14T14:33:40+02:00 0.5 http://www.guerbet.com/news/revenue-september-30-2020 2025-08-14T14:33:40+02:00 0.5 http://www.guerbet.com/insights/role-health-information-technology-optimization-patient-outcomes-and-data-management 2021-07-29T11:09:46+02:00 0.5 http://www.guerbet.com/fr/chiffre-daffaires-au-30-juin-2019 2021-07-29T07:52:19+02:00 0.5 http://www.guerbet.com/news/revenue-30-june-2019 2021-07-29T07:52:19+02:00 0.5 http://www.guerbet.com/fr/resultats-semestriels-2019 2021-07-29T07:52:26+02:00 0.5 http://www.guerbet.com/news/2019-half-year-results 2021-07-29T07:52:26+02:00 0.5 http://www.guerbet.com/fr/chiffre-daffaires-2018 2021-07-29T07:52:32+02:00 0.5 http://www.guerbet.com/news/2018-revenue 2021-07-29T07:52:32+02:00 0.5 http://www.guerbet.com/fr/guerbet-et-ibm-watson-health-annoncent-un-deuxieme-projet-de-codeveloppement-dans-le-cadre-de-leur 2021-07-29T07:52:41+02:00 0.5 http://www.guerbet.com/guerbet-and-ibm-watson-health-announce-second-co-development-project-part-their-strategic 2021-07-29T07:52:41+02:00 0.5 http://www.guerbet.com/fr/guerbet-signe-un-accord-avec-icometrix-pour-la-commercialisation-exclusive-dicobrain-une-solution 2021-07-29T07:52:59+02:00 0.5 http://www.guerbet.com/guerbet-signs-agreement-icometrix-exclusive-distribution-icobrain-artificial-intelligence-medical 2021-07-29T07:52:59+02:00 0.5 http://www.guerbet.com/fr/guerbet-present-its-innovative-solution-offering-interventional-imaging-cirse-2019-barcelona 2021-07-29T07:53:10+02:00 0.5 http://www.guerbet.com/guerbet-present-its-innovative-solution-offering-interventional-imaging-cirse-2019-barcelona 2021-07-29T07:53:10+02:00 0.5 http://www.guerbet.com/fr/guerbet-noue-un-partenariat-strategique-avec-intersystems-pour-renforcer-le-deploiement-de 2021-07-29T07:53:33+02:00 0.5 http://www.guerbet.com/news/guerbet-announces-strategic-partnership-intersystems-extend-deployment-contrastcarer 2021-07-29T07:53:33+02:00 0.5 http://www.guerbet.com/fr/chiffre-daffaires-du-1er-trimestre-2019 2021-07-29T07:53:41+02:00 0.5 http://www.guerbet.com/news/1-st-quarter-2019-revenue 2021-07-29T07:53:41+02:00 0.5 http://www.guerbet.com/fr/approbation-dune-nouvelle-indication-pour-lipiodolr-ultra-fluide-de-guerbet 2021-07-29T07:53:51+02:00 0.5 http://www.guerbet.com/new-indication-approved-guerbets-lipiodolr-ultra-fluid 2021-07-29T07:53:51+02:00 0.5 http://www.guerbet.com/fr/enregistrement-de-vectorior-en-inde-un-dispositif-medical-innovant-pour-les-procedures-ctace 2021-07-29T07:53:57+02:00 0.5 http://www.guerbet.com/news/vectorior-registration-india-innovative-medical-device-ctace-procedures 2021-07-29T07:53:57+02:00 0.5 http://www.guerbet.com/fr/david-hale-nomme-directeur-general-de-guerbet-compter-du-1er-janvier-2020-pour-accelerer-le 2021-07-29T07:54:04+02:00 0.5 http://www.guerbet.com/news/david-hale-appointed-ceo-guerbet-january-1-2020-accelerate-deployment-groups-strategy 2021-07-29T07:54:04+02:00 0.5 http://www.guerbet.com/news/guerbet-participate-75th-annual-meeting-asrm-american-society-reproductive-medicine 2021-07-29T07:54:11+02:00 0.5 http://www.guerbet.com/news/et-2019-guerbet-participate-european-conference-embolotherapy 2020-05-06T13:30:43+02:00 0.5 http://www.guerbet.com/news/mlcto-2019-once-again-guerbet-partners-initiatives-implemented-interventional-cardiologists 2021-07-29T07:58:15+02:00 0.5 http://www.guerbet.com/fr/guerbet-partenaire-de-la-premiere-edition-du-htid 2021-07-29T07:58:30+02:00 0.5 http://www.guerbet.com/news/guerbet-partner-first-htid-edition 2021-07-29T07:58:30+02:00 0.5 http://www.guerbet.com/news/guerbet-strengthens-its-commitment-womens-health 2021-07-29T07:58:36+02:00 0.5 http://www.guerbet.com/fr/approbation-dune-nouvelle-indication-pour-lipiodolr-ultra-fluide-de-guerbet-juin-6 2021-07-29T07:58:43+02:00 0.5 http://www.guerbet.com/new-indication-approved-guerbets-lipiodolr-ultra-fluid-june-6 2021-07-29T07:58:43+02:00 0.5 http://www.guerbet.com/news/guerbet-shows-its-commitment-supporting-professionals-field-interventional-imaging-its-launch 2021-07-29T07:58:50+02:00 0.5 http://www.guerbet.com/news/guerbet-commits-supporting-womens-health-its-launch-specialized-website 2021-07-29T07:58:56+02:00 0.5 http://www.guerbet.com/news/aspire-2019-guerbet-involved-womens-healthcare 2021-07-29T07:59:03+02:00 0.5 http://www.guerbet.com/fr/guerbet-obtient-le-marquage-ce-pour-les-microcatheters-sequrer-et-drakontm-en-imagerie 2021-07-29T07:59:11+02:00 0.5 http://www.guerbet.com/news/guerbet-receives-ce-mark-approval-sequrer-and-drakontm-microcatheters-interventional-imaging 2021-07-29T07:59:11+02:00 0.5 http://www.guerbet.com/news/guerbet-teams-will-attend-iffs-2019 2021-07-29T08:00:15+02:00 0.5 http://www.guerbet.com/news/guerbet-enriches-visitor-experience-tech-gate-during-ecr-2019-vienna 2021-07-29T08:00:30+02:00 0.5 http://www.guerbet.com/fr/guerbet-lance-une-nouvelle-solution-multi-patients-sans-compromis-sur-lefficacite-et-la-securite 2021-07-29T08:03:08+02:00 0.5 http://www.guerbet.com/news/guerbet-launches-new-multi-patient-solution-no-compromise-efficiency-and-patient-safety 2021-07-29T08:03:08+02:00 0.5 http://www.guerbet.com/fr/guerbet-lance-contrastcarer-20 2020-05-07T07:21:51+02:00 0.5 http://www.guerbet.com/news/guerbet-launches-contrastcarer-20 2020-05-07T07:21:51+02:00 0.5 http://www.guerbet.com/fr/les-equipes-guerbet-du-monde-entier-celebrent-la-journee-internationale-de-la-radiologie 2025-07-22T13:41:50+02:00 0.5 http://www.guerbet.com/news/guerbet-teams-around-world-celebrate-international-day-radiology 2025-07-22T13:41:50+02:00 0.5 http://www.guerbet.com/fr/chiffre-daffaires-au-30-septembre-2018 2020-05-07T06:46:07+02:00 0.5 http://www.guerbet.com/news/revenue-30-september-2018 2020-05-07T06:46:07+02:00 0.5 http://www.guerbet.com/fr/guerbet-presente-ses-offres-globales-et-solutions-innovantes-en-imagerie-medicale-diagnostique-et 2025-07-16T17:20:48+02:00 0.5 http://www.guerbet.com/news/guerbet-will-present-its-comprehensive-ranges-and-innovative-solutions-diagnostic-and 2025-07-16T17:20:48+02:00 0.5 http://www.guerbet.com/fr/resultats-semestriels-2018 2020-05-07T06:54:12+02:00 0.5 http://www.guerbet.com/news/2018-half-year-results 2020-05-07T06:54:12+02:00 0.5 http://www.guerbet.com/fr/resultats-annuels-2018 2020-05-07T06:44:28+02:00 0.5 http://www.guerbet.com/news/2018-annual-results 2020-05-07T06:44:28+02:00 0.5 http://www.guerbet.com/fr/guerbet-presente-ses-solutions-innovantes-pour-limagerie-interventionnelle-au-congres-annuel-du 2020-05-07T06:56:19+02:00 0.5 http://www.guerbet.com/news/guerbet-present-its-innovative-solutions-offering-interventional-imaging-cirse-2018 2020-05-07T06:56:19+02:00 0.5 http://www.guerbet.com/news/new-indication-approved-guerbets-lipiodolr-ultra-fluid-2018 2025-07-22T13:41:51+02:00 0.5 http://www.guerbet.com/fr/guerbet-et-ibm-watson-health-annoncent-un-partenariat-strategique-alliant-lintelligence 2020-10-29T13:20:17+01:00 0.5 http://www.guerbet.com/news/guerbet-and-ibm-watson-health-announce-strategic-partnership-artificial-intelligence-medical 2020-10-29T13:20:17+01:00 0.5 http://www.guerbet.com/fr/les-equipes-guerbet-presentes-leshre-2018 2020-05-07T07:05:55+02:00 0.5 http://www.guerbet.com/news/guerbet-teams-will-attend-eshre-2018 2020-05-07T07:05:55+02:00 0.5 http://www.guerbet.com/fr/guerbet-celebre-le-50eme-anniversaire-de-son-site-de-production-pharmaceutique-et-de-rd-aulnay-sous 2020-05-07T07:14:35+02:00 0.5 http://www.guerbet.com/guerbet-celebre-le-50eme-anniversaire-de-son-site-de-production-pharmaceutique-et-de-rd-aulnay-sous 2020-05-07T07:14:35+02:00 0.5 http://www.guerbet.com/fr/guerbet-lance-une-nouvelle-solution-multi-patients-sans-compromis-sur-lefficacite-et-la-securite-0 2020-05-07T07:26:20+02:00 0.5 http://www.guerbet.com/guerbet-lance-une-nouvelle-solution-multi-patients-sans-compromis-sur-lefficacite-et-la-securite 2020-05-07T07:26:20+02:00 0.5 http://www.guerbet.com/insights/less-pain-more-gain-exploring-without-scalpel-day-dr-roberto-iezzi 2021-07-29T11:09:59+02:00 0.5 http://www.guerbet.com/fr/guerbet-integre-la-liste-b-du-cdp-pour-son-action-en-matiere-de-lutte-contre-le-rechauffement 2020-05-07T06:22:42+02:00 0.5 http://www.guerbet.com/news/guerbet-receives-b-rating-cdp-actions-taken-prevent-global-warming 2020-05-07T06:22:42+02:00 0.5 http://www.guerbet.com/fr/enregistrement-de-vectorior-taiwan-un-dispositif-medical-innovant-pour-loncologie-interventionnelle 2020-05-07T06:24:45+02:00 0.5 http://www.guerbet.com/news/vectorior-registration-taiwan-innovative-medical-device-interventional-oncology 2020-05-07T06:24:45+02:00 0.5 http://www.guerbet.com/fr/lipiodolr-ultra-fluid-indique-pour-lhysterosalpingographie-hsg-chez-les-femmes-effectuant-un-bilan 2020-05-07T06:26:14+02:00 0.5 http://www.guerbet.com/news/lipiodolr-ultra-fluid-indicated-hysterosalpingography-hsg-women-undergoing-infertility-workup 2020-05-07T06:26:14+02:00 0.5 http://www.guerbet.com/fr/chiffre-daffaires-2019 2020-05-07T06:28:46+02:00 0.5 http://www.guerbet.com/news/2019-revenue 2020-05-07T06:28:46+02:00 0.5 http://www.guerbet.com/fr/journee-internationale-des-femmes-les-actions-mises-en-oeuvre-par-guerbet 2021-07-29T11:10:11+02:00 0.5 http://www.guerbet.com/insights/international-womens-day-guerbet-takes-action 2021-07-29T11:10:11+02:00 0.5 http://www.guerbet.com/fr/publication-dans-le-new-england-journal-medicine-de-h2oil-essai-clinique-randomise-dedie-letude-de 2025-07-22T13:41:50+02:00 0.5 http://www.guerbet.com/news/h2oil-trial-using-lipiodolr-uf-hysterosalpingography-published-new-england-journal-medicine 2025-07-22T13:41:50+02:00 0.5 http://www.guerbet.com/fr/covid-19 2021-09-16T09:18:36+02:00 0.5 http://www.guerbet.com/insights/covid-19 2021-09-16T09:18:36+02:00 0.5 http://www.guerbet.com/fr/la-hongrie-et-les-pays-bas-approuvent-lipiodolr-ultra-fluid-pour-lhysterosalpingographie-chez-les 2020-06-30T10:43:51+02:00 0.5 http://www.guerbet.com/news/hungary-and-netherlands-approve-lipiodolr-ultra-fluid-hysterosalpingography-women-undergoing 2020-06-30T10:43:51+02:00 0.5 http://www.guerbet.com/fr/resultats-annuels-2019 2020-05-07T07:28:27+02:00 0.5 http://www.guerbet.com/news/2019-annual-results 2020-05-07T07:28:27+02:00 0.5 http://www.guerbet.com/insights/what-place-chest-ct-covid-19-diagnosis-particularly-france 2021-07-29T11:06:26+02:00 0.5 http://www.guerbet.com/insights/chest-ct-diagnosis-plays-key-role-patient-care-management-across-world 2021-07-29T11:06:33+02:00 0.5 http://www.guerbet.com/fr/chiffre-daffaires-du-1er-trimestre-2020 2020-10-22T16:10:08+02:00 0.5 http://www.guerbet.com/1st-quarter-2020-revenue 2020-10-22T16:10:08+02:00 0.5 http://www.guerbet.com/fr/nos-equipes-des-services-techniques-se-mobilisent-pendant-cette-crise-du-covid-19-pour-accompagner 2021-07-29T11:06:40+02:00 0.5 http://www.guerbet.com/insights/guerbet-services-teams-are-mobilized-support-healthcare-professionals-during-covid-19 2021-07-29T11:06:40+02:00 0.5 http://www.guerbet.com/insights/webinar-leveraging-artificial-intelligence-covid-19-environment 2021-07-29T11:06:46+02:00 0.5 http://www.guerbet.com/fr/enregistrement-de-vectorior-au-canada-un-dispositif-medical-innovant-pour-les-procedures-doncologie 2020-05-19T15:15:40+02:00 0.5 http://www.guerbet.com/vectorior-approved-canada-innovative-medical-device-interventional-oncology-procedures 2020-05-19T15:15:40+02:00 0.5 http://www.guerbet.com/fr/la-republique-tcheque-approuve-lipiodolr-ultra-fluid-pour-lhysterosalpingographie-chez-les-femmes 2020-12-08T08:51:50+01:00 0.5 http://www.guerbet.com/czech-republic-approves-lipiodolr-ultra-fluid-hysterosalpingography-women-undergoing-infertility 2020-12-08T08:51:50+01:00 0.5 http://www.guerbet.com/fr/petra-zalabak-nommee-directrice-des-ressources-humaines 2020-05-26T06:24:35+02:00 0.5 http://www.guerbet.com/petra-zalabak-appointed-human-resources-vp 2020-05-26T06:24:35+02:00 0.5 http://www.guerbet.com/insights/symposium-supported-esgar-2020 2021-07-29T11:06:53+02:00 0.5 http://www.guerbet.com/fr/actualites/ladministration-nationale-des-produits-medicaux-nmpa-approuve-lipiodolr-ultra-fluide 2021-05-04T09:16:09+02:00 0.5 http://www.guerbet.com/national-medical-products-administration-nmpa-approves-lipiodolr-ultra-fluid-trans-arterial 2021-05-04T09:16:09+02:00 0.5 http://www.guerbet.com/fr/la-therapeutic-goods-administration-tga-approuve-la-fois-vectorior-et-une-nouvelle-indication-pour 2020-10-22T16:18:15+02:00 0.5 http://www.guerbet.com/therapeutic-goods-administration-tga-approves-both-additional-indication-guerbets-lipiodolr-ultra 2020-10-22T16:18:15+02:00 0.5 http://www.guerbet.com/fr/guerbet-sengage-aupres-des-professionnels-de-sante-avec-deux-gammes-de-consommables-selectionnees 2020-06-30T15:26:21+02:00 0.5 http://www.guerbet.com/guerbet-shows-its-commitment-healthcare-professionals-two-ranges-consumables-selected-their 2020-06-30T15:26:21+02:00 0.5 http://www.guerbet.com/fr/optimisation-du-schema-industriel-du-groupe 2025-08-14T14:42:23+02:00 0.5 http://www.guerbet.com/news/guerbet-optimizes-its-industrial-network 2025-08-14T14:42:23+02:00 0.5 http://www.guerbet.com/insights/guerbet-ai-satellite-symposium-ecr-2020 2021-07-29T11:07:15+02:00 0.5 http://www.guerbet.com/insights/current-and-future-place-radiology-covid-19-management-impacts-and-adjustments-view 2021-08-30T17:54:29+02:00 0.5 http://www.guerbet.com/fr/chiffre-daffaires-au-30-juin-2020 2020-07-23T15:48:22+02:00 0.5 http://www.guerbet.com/news/revenue-june-30-2020 2020-07-23T15:48:22+02:00 0.5 http://www.guerbet.com/insights/covid-19-management-patient-pathway-diagnostic-treatments-current-and-development 2021-08-30T17:48:15+02:00 0.5 http://www.guerbet.com/fr/lipiodolr-ultra-fluid-indique-dans-lhysterosalpingographie-hsg-pour-le-rincage-tubaire-chez-les 2025-08-14T14:40:47+02:00 0.5 http://www.guerbet.com/news/lipiodolr-ultra-fluid-indicated-hysterosalpingography-hsg-tubal-flushing-women-undergoing 2025-08-14T14:40:47+02:00 0.5 http://www.guerbet.com/fr/insights/le-support-technique-guerbet-france-mobilise-aupres-des-radiologues-pour-garantir-la 2022-03-16T18:29:02+01:00 0.5 http://www.guerbet.com/insights/webinar-liver-focal-lesions-where-do-we-stand-detection-and-interest-ai 2022-03-16T18:29:02+01:00 0.5 http://www.guerbet.com/fr/guerbet-renforce-son-comite-executif-afin-daccelerer-sa-transformation 2025-08-14T14:36:06+02:00 0.5 http://www.guerbet.com/news/guerbet-strengthens-its-executive-committee-step-its-transformation 2025-08-14T14:36:06+02:00 0.5 http://www.guerbet.com/fr/resultats-semestriels-2020 2025-08-14T14:34:33+02:00 0.5 http://www.guerbet.com/news/2020-half-year-results 2025-08-14T14:34:33+02:00 0.5 http://www.guerbet.com/insights/world-cancer-research-day-combining-immunotherapy-interventional-radiology-hepatocellular 2021-07-29T11:07:29+02:00 0.5 http://www.guerbet.com/insights/thinking-having-baby 2021-07-29T11:07:36+02:00 0.5 http://www.guerbet.com/fr/actualites/un-second-administrateur-representant-les-salaries-rejoint-le-conseil-dadministration-de 2020-10-29T07:00:45+01:00 0.5 http://www.guerbet.com/news/guerbet-appoints-second-director-representing-employees-its-board 2020-10-29T07:00:45+01:00 0.5 http://www.guerbet.com/fr/guerbet-sengage-aupres-des-patients-touches-par-linfertilite-loccasion-de-la-semaine-de-la 2025-08-14T14:32:53+02:00 0.5 http://www.guerbet.com/news/guerbet-commits-patients-affected-infertility-during-european-fertility-week 2025-08-14T14:32:53+02:00 0.5 http://www.guerbet.com/insights/european-fertility-patient-organizations-working-together 2021-07-29T11:07:43+02:00 0.5 http://www.guerbet.com/fr/le-royaume-uni-approuve-lipiodolr-ultra-fluid-pour-lhysterosalpingographie-chez-les-femmes 2025-08-14T14:27:52+02:00 0.5 http://www.guerbet.com/news/uk-approves-lipiodolr-ultra-fluid-hysterosalpingography-women-undergoing-infertility-workup 2025-08-14T14:27:52+02:00 0.5 http://www.guerbet.com/fr/indice-vert-cahpp-guerbet-obtient-le-label 2020-12-14T16:43:01+01:00 0.5 http://www.guerbet.com/indice-vert-cahpp-guerbet-obtient-le-label 2020-12-14T16:43:01+01:00 0.5 http://www.guerbet.com/fr/guerbet-obtient-la-note-du-cdp-pour-son-engagement-dans-la-lutte-contre-le-rechauffement-climatique 2025-08-14T14:26:56+02:00 0.5 http://www.guerbet.com/news/guerbet-makes-cdp-grade-its-commitment-fight-against-global-warming 2025-08-14T14:26:56+02:00 0.5 http://www.guerbet.com/fr/notre-directeur-general-david-hale-vous-partage-ses-voeux-de-la-part-de-toutes-les-equipes-guerbet 2021-07-29T11:07:55+02:00 0.5 http://www.guerbet.com/insights/david-hale-our-ceo-extends-his-best-wishes-behalf-everyone-guerbet 2021-07-29T11:07:55+02:00 0.5 http://www.guerbet.com/insights/without-scalpel-day-no-surgery-no-stitches-no-scars 2021-07-29T11:10:19+02:00 0.5 http://www.guerbet.com/fr/responsabilite-sociale-et-environnementale-gaia-index-2020-guerbet-classe-premier-de-la-categorie 2021-01-19T16:48:49+01:00 0.5 http://www.guerbet.com/2020-corporate-social-responsibility-gaia-index-guerbet-ranks-top-healthcare-category 2021-01-19T16:48:49+01:00 0.5 http://www.guerbet.com/fr/sarah-dayre-rejoint-le-comite-executif-de-guerbet-en-tant-que-directrice-des-operations-techniques 2021-01-28T06:42:28+01:00 0.5 http://www.guerbet.com/sarah-dayre-joins-guerbet-executive-committee-senior-vice-president-technical-operations 2021-01-28T06:42:28+01:00 0.5 http://www.guerbet.com/fr/actualites/chiffre-daffaires-2020 2025-07-22T13:48:16+02:00 0.5 http://www.guerbet.com/news/2020-revenue 2025-07-22T13:48:16+02:00 0.5 http://www.guerbet.com/fr/lancement-de-loffre-optiprotecttm-3s-une-nouvelle-gamme-de-services-techniques-pour-les-solutions 2025-08-05T11:42:00+02:00 0.5 http://www.guerbet.com/news/launch-optiprotecttm-3s-new-range-technical-services-guerbet-injection-solutions 2025-08-05T11:42:00+02:00 0.5 http://www.guerbet.com/insights/guerbet-celebrates-women-interventional-radiology-international-womens-day 2021-07-29T11:08:03+02:00 0.5 http://www.guerbet.com/insights/demand-webinar-adaptative-measures-radiology-practice-after-2020 2022-02-09T12:54:13+01:00 0.5 http://www.guerbet.com/insights/webinar-role-mri-breast-cancer-management-landscape-and-perspectives 2021-08-05T09:53:37+02:00 0.5 http://www.guerbet.com/fr/gadopiclenol-resultats-positifs-pour-les-deux-essais-cliniques-de-phase-iii 2025-08-05T11:15:53+02:00 0.5 http://www.guerbet.com/news/gadopiclenol-positive-results-for-phase-iii-clinical-trials 2025-08-05T11:15:53+02:00 0.5 http://www.guerbet.com/fr/resultats-annuels-2020 2025-08-05T11:41:37+02:00 0.5 http://www.guerbet.com/news/2020-annual-results 2025-08-05T11:41:37+02:00 0.5 http://www.guerbet.com/fr/precisions-sur-les-perspectives-financieres-2021 2025-08-05T11:41:13+02:00 0.5 http://www.guerbet.com/news/additional-information-related-2021-financial-outlook 2025-08-05T11:41:13+02:00 0.5 http://www.guerbet.com/fr/guerbet-devoile-sa-raison-detre-guide-strategique-pour-ses-actions-et-decisions 2021-05-04T09:11:36+02:00 0.5 http://www.guerbet.com/guerbet-reveals-its-purpose-strategic-guide-its-actions-and-decisions 2021-05-04T09:11:36+02:00 0.5 http://www.guerbet.com/our-purpose-our-strategic-compass-sustainable-growth 2021-07-29T11:08:35+02:00 0.5 http://www.guerbet.com/insights/how-ai-can-help-you-focus-patient-outcomes 2021-07-29T11:08:45+02:00 0.5 http://www.guerbet.com/fr/actualites/lautorite-sud-africaine-de-reglementation-des-produits-de-sante-sahpra-approuve-lipiodol 2021-04-08T19:15:49+02:00 0.5 http://www.guerbet.com/south-african-health-products-regulatory-authority-sahpra-approves-lipiodolr-ultra-fluid 2021-04-08T19:15:49+02:00 0.5 http://www.guerbet.com/fr/chiffre-daffaires-du-1er-trimestre-2021 2025-08-05T11:39:16+02:00 0.5 http://www.guerbet.com/news/q1-2021-revenue 2025-08-05T11:39:16+02:00 0.5 http://www.guerbet.com/insights/demand-webinar-cardiovascular-cta-tips-and-tricks-injection-strategies-adult-and-pediatric 2022-01-03T16:14:54+01:00 0.5 http://www.guerbet.com/fr/marc-massiot-est-nomme-administrateur-de-guerbet 2025-08-05T11:38:53+02:00 0.5 http://www.guerbet.com/news/marc-massiot-appointed-guerbets-board-directors 2025-08-05T11:38:53+02:00 0.5 http://www.guerbet.com/insights/webinar-new-horizons-infertility-management-use-contrast-medium-hysterosalpingography 2021-10-01T15:46:06+02:00 0.5 http://www.guerbet.com/news/statement-regarding-compliance-european-medical-device-regulation-regulation-eu-2017745-mdr 2025-08-05T11:38:30+02:00 0.5 http://www.guerbet.com/fr/chiffre-daffaires-du-1er-semestre-2021 2025-08-05T11:37:41+02:00 0.5 http://www.guerbet.com/news/first-half-2021-revenue 2025-08-05T11:37:41+02:00 0.5 http://www.guerbet.com/insights/challenge-your-expertise-advanced-abdominal-clinical-cases 2021-10-06T13:14:50+02:00 0.5 http://www.guerbet.com/insights/meet-experts-liquid-embolization-gi-bleeding 2022-02-22T08:55:34+01:00 0.5 http://www.guerbet.com/insights/meet-experts-trans-pedal-trans-nodal-lymphangiography-diagnostic-set-1 2021-09-13T13:14:20+02:00 0.5 http://www.guerbet.com/insights/meet-experts-towards-ctace-standardization 2021-09-13T13:19:04+02:00 0.5 http://www.guerbet.com/insights/demand-webinar-obesity-management-and-need-adjusted-injection-protocols 2022-04-07T09:40:33+02:00 0.5 http://www.guerbet.com/broader-spectrum-hcc-management-demand 2022-04-07T08:38:21+02:00 0.5 http://www.guerbet.com/insights/cirse-2021-educational-sessions-replay 2021-10-13T12:52:11+02:00 0.5 http://www.guerbet.com/insights/webinar-lymphangiography-october-7 2021-09-27T10:43:26+02:00 0.5 http://www.guerbet.com/fr/resultats-semestriels-2021 2025-08-05T11:37:17+02:00 0.5 http://www.guerbet.com/news/2021-half-year-results 2025-08-05T11:37:17+02:00 0.5 http://www.guerbet.com/fr/guerbet-participe-lipo-de-nh-theraguix-sur-euronext-growth-acteur-des-biotechnologies-innovantes 2025-08-05T11:36:41+02:00 0.5 http://www.guerbet.com/news/guerbet-contributes-nh-theraguix-ipo-euronext-growth-specialist-innovative-biotechnologies 2025-08-05T11:36:41+02:00 0.5 http://www.guerbet.com/fr/chiffre-daffaires-au-30-septembre-2021 2025-08-05T11:36:02+02:00 0.5 http://www.guerbet.com/news/sales-september-30-2021 2025-08-05T11:36:02+02:00 0.5 http://www.guerbet.com/insights/new-horizons-fertility-management-exploring-role-hysterosalpingography-demand 2021-10-27T13:26:18+02:00 0.5 http://www.guerbet.com/insights/guerbet-celebrates-international-day-radiology-idor-2021 2021-11-08T12:16:40+01:00 0.5 http://www.guerbet.com/insights/update-iodinated-contrast-media-administration-impact-new-ct-technology 2025-08-31T13:51:15+02:00 0.5 http://www.guerbet.com/fr/guerbet-et-bracco-imaging-annoncent-un-accord-de-collaboration-strategique-mondial-concernant 2025-08-05T11:35:03+02:00 0.5 http://www.guerbet.com/news/guerbet-and-bracco-imaging-announce-global-strategic-collaboration-agreement-gadopiclenol 2025-08-05T11:35:03+02:00 0.5 http://www.guerbet.com/fr/classement-gaia-index-2021-guerbet-consolide-sa-place-de-leader-de-la-categorie-sante 2022-01-04T16:42:41+01:00 0.5 http://www.guerbet.com/gaia-index-2021-guerbet-consolidates-its-position-leader-healthcare-category 2022-01-04T16:42:41+01:00 0.5 http://www.guerbet.com/news/guerbet-announces-appointment-jared-houk-commercial-vice-president-north-america 2025-08-05T11:48:02+02:00 0.5 http://www.guerbet.com/insights/without-scalpel-day-2022 2022-01-17T14:07:32+01:00 0.5 http://www.guerbet.com/fr/insights/guerbet-et-bracco-imaging-annoncent-un-accord-de-collaboration-strategique-mondial 2022-02-02T08:09:57+01:00 0.5 http://www.guerbet.com/insights/guerbet-and-bracco-imaging-announce-global-strategic-collaboration-agreement-gadopiclenol 2022-02-02T08:09:57+01:00 0.5 http://www.guerbet.com/insights/ecr-2022-overture-demand-symposium 2022-03-03T09:52:04+01:00 0.5 http://www.guerbet.com/fr/actualites/chiffre-daffaires-2021 2022-02-10T16:46:40+01:00 0.5 http://www.guerbet.com/news/2021-revenue 2022-02-10T16:46:40+01:00 0.5 http://www.guerbet.com/insights/chotheria-project-aims-revolutionize-cholangiocarcinoma-care 2022-02-12T08:55:57+01:00 0.5 http://www.guerbet.com/insights/demand-ecio-2022 2022-06-29T07:37:12+02:00 0.5 http://www.guerbet.com/fr/actualites/guerbet-elargit-son-portefeuille-de-microcatheters-et-de-fils-guides-pour-limagerie 2022-03-07T16:59:21+01:00 0.5 http://www.guerbet.com/news/guerbet-expands-portfolio-microcatheters-and-guidewires-interventional-imaging-and 2022-03-07T16:59:21+01:00 0.5 http://www.guerbet.com/fr/resultats-annuels-2021 2022-03-23T16:45:19+01:00 0.5 http://www.guerbet.com/2021-annual-results 2022-03-23T16:45:19+01:00 0.5 http://www.guerbet.com/fr/lema-et-la-fda-acceptent-devaluer-les-dossiers-de-demande-dautorisation-de-mise-sur-le-marche-de 2025-08-05T11:18:44+02:00 0.5 http://www.guerbet.com/news/gadopiclenol-marketing-authorization-dossier-submissions-accepted-for-review-by-ema-and-fda 2025-08-05T11:18:44+02:00 0.5 http://www.guerbet.com/fr/guerbet-renforce-son-comite-executif-avec-la-nomination-de-charlotte-bamiere-directrice-des 2022-04-06T06:29:28+02:00 0.5 http://www.guerbet.com/guerbet-strengthens-its-executive-committee-appointment-charlotte-bamiere-general-counsel 2022-04-06T06:29:28+02:00 0.5 http://www.guerbet.com/management-postoperative-lymphorrhea-demand 2022-04-06T15:24:38+02:00 0.5 http://www.guerbet.com/lymphangiography-technique-demand 2022-04-06T15:24:51+02:00 0.5 http://www.guerbet.com/pelvic-embolization-expand-your-tool-box-demand 2022-04-06T15:34:35+02:00 0.5 http://www.guerbet.com/sequrer-microcatheters-more-targeted-delivery-demand 2022-04-07T08:37:48+02:00 0.5 http://www.guerbet.com/fr/chiffre-daffaires-du-1er-trimestre-2022 2025-08-05T11:49:14+02:00 0.5 http://www.guerbet.com/news/q1-2022-sales 2025-08-05T11:49:14+02:00 0.5 http://www.guerbet.com/insights/et-demand-symposium 2022-06-29T12:21:38+02:00 0.5 http://www.guerbet.com/insights/eshre22-ondemand 2022-07-21T07:41:07+02:00 0.5 http://www.guerbet.com/fr/actualites/guerbet-recoit-lapprobation-de-lema-de-son-nom-de-marque-eluciremr-pour-gadopiclenol 2025-08-05T11:17:24+02:00 0.5 http://www.guerbet.com/news/guerbet-receives-ema-acceptance-of-elucirem-as-the-brand-name-for-gadopiclenol 2025-08-05T11:17:24+02:00 0.5 http://www.guerbet.com/insights/webinar-demand-reducing-contrast-media-volume-ct-imaging-paediatrics-adults 2025-08-31T13:48:49+02:00 0.5 http://www.guerbet.com/esgar-2022-guerbet-symposium 2023-07-07T08:49:26+02:00 0.5 http://www.guerbet.com/fr/chiffre-daffaires-du-1er-semestre-2022 2025-08-05T11:49:33+02:00 0.5 http://www.guerbet.com/news/h1-2022-sales 2025-08-05T11:49:33+02:00 0.5 http://www.guerbet.com/insights/demand-cirse22 2022-08-23T14:29:40+02:00 0.5 http://www.guerbet.com/gbca-use-and-environment-current-and-future-trends-ecr-22-demand-symposium 2022-09-05T09:43:41+02:00 0.5 http://www.guerbet.com/ai-prostate-cancer-imaging-cutting-edge-ecr-22-demand-symposium 2022-09-05T09:49:34+02:00 0.5 http://www.guerbet.com/breast-imaging-using-mri-or-contrast-enhanced-mammography-friends-or-foes-ecr-22-demand-symposium 2022-09-21T06:45:28+02:00 0.5 http://www.guerbet.com/multiple-sclerosis-dementia-how-can-mri-and-ai-be-part-clinical-role-patient-care-path-ecr-22 2022-09-05T11:43:40+02:00 0.5 http://www.guerbet.com/contrast-enhanced-mammography-clinical-implementation-and-standardized-reporting-ecr-22-demand 2022-09-21T06:42:36+02:00 0.5 http://www.guerbet.com/state-art-mr-contrast-media-2022-ecr-22-demand-workshop 2022-09-05T12:45:01+02:00 0.5 http://www.guerbet.com/helpful-hints-optimise-your-mri-examination-ecr-22-demand-workshop 2022-09-05T13:00:53+02:00 0.5 http://www.guerbet.com/mri-contrast-agents-when-non-clinical-research-meets-actual-or-future-clinical-practice-ecr-22 2022-09-05T12:59:58+02:00 0.5 http://www.guerbet.com/sage-review-real-life-safety-data-international-pharmacovigilance-databases-ecr-22-demand-workshop 2022-09-05T13:09:33+02:00 0.5 http://www.guerbet.com/fr/resultats-semestriels-2022 2025-08-05T11:50:00+02:00 0.5 http://www.guerbet.com/news/2022-half-year-results 2025-08-05T11:50:00+02:00 0.5 http://www.guerbet.com/fr/guerbet-annonce-lapprobation-par-la-fda-du-produit-de-contraste-eluciremtm-gadopiclenol 2023-01-16T10:35:33+01:00 0.5 http://www.guerbet.com/news/guerbet-announces-us-food-and-drug-administration-fda-approval-eluciremtm-gadopiclenol 2023-01-16T10:35:33+01:00 0.5 http://www.guerbet.com/fr/guerbet-obtient-le-financement-dun-million-deuros-de-la-banque-publique-dinvestissement-bpi-projet 2025-08-05T11:50:58+02:00 0.5 http://www.guerbet.com/news/guerbet-obtains-one-million-euros-public-funding-bpifrance-france-2030-investment-plan-project 2025-08-05T11:50:58+02:00 0.5 http://www.guerbet.com/lymphatic-system-new-horizons-visualization-and-treatment 2022-09-28T08:34:38+02:00 0.5 http://www.guerbet.com/beyond-access-does-catheter-choice-influence-procedure-success 2022-09-28T08:34:56+02:00 0.5 http://www.guerbet.com/optimizing-treatment-approaches-hcc-today 2022-09-28T08:35:03+02:00 0.5 http://www.guerbet.com/fr/chiffre-daffaires-au-30-septembre-2022 2025-08-05T11:48:49+02:00 0.5 http://www.guerbet.com/news/revenue-september-30-2022 2025-08-05T11:48:49+02:00 0.5 http://www.guerbet.com/fr/guerbet-annonce-un-changement-de-gouvernance-pour-ses-projets-dintelligence-artificielle 2025-08-05T11:51:35+02:00 0.5 http://www.guerbet.com/news/guerbet-announces-change-governance-its-artificial-intelligence-projects 2025-08-05T11:51:35+02:00 0.5 http://www.guerbet.com/fr/insights/idor-2022-imagerie-par-resonance-magnetique-des-avancees-pour-un-meilleur-diagnostic-des 2022-11-09T14:56:02+01:00 0.5 http://www.guerbet.com/insights/idor-2022-magnetic-resonance-imaging-breakthroughs-better-diagnosis-cancers 2022-11-09T14:56:02+01:00 0.5 http://www.guerbet.com/2022-year-review-guerbet 2023-01-11T08:52:32+01:00 0.5 http://www.guerbet.com/fr/intrasense-ouvre-son-capital-au-groupe-guerbet-qui-annonce-son-intention-de-deposer-un-projet 2023-02-09T13:00:33+01:00 0.5 http://www.guerbet.com/intrasense-opens-its-share-capital-guerbet-group-which-announces-its-intent-file-voluntary-tender 2023-02-09T13:00:33+01:00 0.5 http://www.guerbet.com/fr/priorites-strategiques-2023 2023-02-09T12:56:12+01:00 0.5 http://www.guerbet.com/2023-strategic-priorities 2023-02-09T12:56:12+01:00 0.5 http://www.guerbet.com/fr/chiffre-daffaires-2022 2023-12-22T12:47:51+01:00 0.5 http://www.guerbet.com/2022-revenue 2023-12-22T12:47:51+01:00 0.5 http://www.guerbet.com/ecr-2023-demand-symposium 2023-07-10T15:12:50+02:00 0.5 http://www.guerbet.com/news/2022-annual-results 2025-08-14T14:52:17+02:00 0.5 http://www.guerbet.com/news/q1-2023-revenue 2023-12-22T08:28:49+01:00 0.5 http://www.guerbet.com/esgar-2023-guerbet-symposium 2023-07-12T14:03:37+02:00 0.5 http://www.guerbet.com/changes-guerbets-board-directors 2023-05-26T15:50:04+02:00 0.5 http://www.guerbet.com/world-environment-day-guerbet-pursues-its-commitment-climate 2023-06-07T14:30:52+02:00 0.5 http://www.guerbet.com/fr/guerbet-renforce-son-comite-executif-avec-deux-nouvelles-nominations 2025-08-14T14:51:00+02:00 0.5 http://www.guerbet.com/news/guerbet-strengthens-its-executive-committee-two-new-appointments-accelerate-its-commercial-and 2025-08-14T14:51:00+02:00 0.5 http://www.guerbet.com/fr/guerbet-remporte-le-pi-cai-grand-challenge-sur-la-detection-du-cancer-de-la-prostate 2025-08-14T14:50:17+02:00 0.5 http://www.guerbet.com/news/guerbet-wins-pi-cai-grand-challenge-detection-prostate-cancer 2025-08-14T14:50:17+02:00 0.5 http://www.guerbet.com/fr/chiffre-daffaires-du-1er-semestre-2023 2025-08-14T14:49:46+02:00 0.5 http://www.guerbet.com/news/first-half-2023-revenue 2025-08-14T14:49:46+02:00 0.5 http://www.guerbet.com/fr/resultats-semestriels-2023 2025-08-14T14:49:18+02:00 0.5 http://www.guerbet.com/news/half-year-results-2023 2025-08-14T14:49:18+02:00 0.5 http://www.guerbet.com/fr/le-chmp-rend-un-avis-favorable-en-vue-de-loctroi-dune-autorisation-de-mise-sur-le-marche-dans-lue 2023-12-22T12:34:30+01:00 0.5 http://www.guerbet.com/le-chmp-rend-un-avis-favorable-en-vue-de-loctroi-dune-autorisation-de-mise-sur-le-marche-dans-lue 2023-12-22T12:34:30+01:00 0.5 http://www.guerbet.com/news/chmp-issues-opinion-favour-granting-eu-marketing-authorisation-eluciremtm-gadopiclenol 2025-08-14T14:48:48+02:00 0.5 http://www.guerbet.com/news/revenue-30-september-2023 2025-08-14T14:48:14+02:00 0.5 http://www.guerbet.com/news/guerbet-announces-marketing-authorisation-approval-eluciremtm-gadopiclenol-european-union 2025-08-14T14:47:37+02:00 0.5 http://www.guerbet.com/fr/guerbet-nomme-par-linstitut-choiseul 2024-01-12T14:59:04+01:00 0.5 http://www.guerbet.com/insights/guerbet-selected-institute-choiseul 2024-01-12T14:59:04+01:00 0.5 http://www.guerbet.com/fr/actualites/michel-guerbet-figure-historique-du-groupe-est-decede 2024-01-28T20:19:54+01:00 0.5 http://www.guerbet.com/news/michel-guerbet-historic-and-iconic-figure-group-passed-away 2024-01-28T20:19:54+01:00 0.5 http://www.guerbet.com/guerbet-forefront-radiological-innovation-european-congress-radiology-ecr-2024 2024-02-06T11:34:29+01:00 0.5 http://www.guerbet.com/2023-revenue 2024-02-08T17:47:44+01:00 0.5 http://www.guerbet.com/news/guerbet-launch-solar-project-power-18-pharmaceutical-operations-dublin 2025-08-14T14:57:24+02:00 0.5 http://www.guerbet.com/fr/annonce-organisationnelle 2025-08-14T14:56:56+02:00 0.5 http://www.guerbet.com/news/organization-announcement-executive-committee 2025-08-14T14:56:56+02:00 0.5 http://www.guerbet.com/fr/evolution-du-conseil-dadministration 2025-08-14T14:55:28+02:00 0.5 http://www.guerbet.com/news/change-guerbets-board-directors 2025-08-14T14:55:28+02:00 0.5 http://www.guerbet.com/fr/resultats-annuels-2023 2025-08-14T14:56:12+02:00 0.5 http://www.guerbet.com/news/2023-full-year-results 2025-08-14T14:56:12+02:00 0.5 http://www.guerbet.com/intrasense-and-guerbet-announce-ce-certification-myrian-212-enhanced-guerbets-prostate-ai 2024-04-08T16:28:38+02:00 0.5 http://www.guerbet.com/first-eluciremtm-gadopiclenol-injection-administered-european-patients-mri-scan 2024-04-23T06:29:23+02:00 0.5 http://www.guerbet.com/news/q1-2024-revenue 2025-08-14T14:54:57+02:00 0.5 http://www.guerbet.com/news/nuclidium-and-guerbet-form-strategic-partnership-support-advancement-targeted-copper-based 2025-07-27T19:17:02+02:00 0.5 http://www.guerbet.com/hugues-lecat-appointed-chairman-board-directors-guerbet 2024-05-24T16:04:13+02:00 0.5 http://www.guerbet.com/insights/guerbet-french-business-news-channel-bfmbusiness 2024-06-13T15:58:14+02:00 0.5 http://www.guerbet.com/insights/way-responsible-procurement 2024-06-05T16:36:26+02:00 0.5 http://www.guerbet.com/h1-2024-revenue 2024-07-25T15:55:53+02:00 0.5 http://www.guerbet.com/news/guerbet-sell-its-urological-imaging-systems-business-assets-del-medical 2025-08-14T14:54:26+02:00 0.5 http://www.guerbet.com/h1-2024-results 2024-10-24T12:37:07+02:00 0.5 http://www.guerbet.com/news/gadopiclenol-marketed-under-name-eluciremr-guerbet-receives-jfr-2024-innovation-award-jurys 2025-08-14T14:53:59+02:00 0.5 http://www.guerbet.com/fr/chiffre-daffaires-au-30-septembre-2024 2025-08-14T14:53:22+02:00 0.5 http://www.guerbet.com/news/revenue-september-30-2024 2025-08-14T14:53:22+02:00 0.5 http://www.guerbet.com/fr/guerbet-dans-se-dit-tout-sur-lhemicycle-tv 2024-10-25T15:13:06+02:00 0.5 http://www.guerbet.com/guerbet-se-dit-tout-lhemicycle-tv 2024-10-25T15:13:06+02:00 0.5 http://www.guerbet.com/guerbet-intrasense-gustave-roussy-and-university-hospital-angers-receive-eu59m-financing-bpifrance 2024-12-03T17:07:26+01:00 0.5 http://www.guerbet.com/fr/insights/guerbet-une-nouvelle-fois-nomme-par-linstitut-choiseul 2025-10-08T10:14:33+02:00 0.5 http://www.guerbet.com/news/us-food-and-drug-administration-fda-grants-breakthrough-device-status-guerbet-innovation 2025-08-14T15:00:42+02:00 0.5 http://www.guerbet.com/news/2024-revenue 2025-08-14T15:00:12+02:00 0.5 http://www.guerbet.com/fr/duoncotm-bone-premier-algorithme-dia-marque-ce-pour-la-detection-automatique-des-lesions-osseuses 2025-08-14T15:01:10+02:00 0.5 http://www.guerbet.com/news/duoncotm-bone-first-ce-marked-ai-algorithm-automatic-detection-bone-lesions-ct-scan 2025-08-14T15:01:10+02:00 0.5 http://www.guerbet.com/fr/la-us-food-and-drug-administration-fda-accorde-le-statut-de-breakthrough-device-linnovation-0 2025-08-14T15:01:53+02:00 0.5 http://www.guerbet.com/news/us-food-and-drug-administration-fda-grants-breakthrough-device-status-guerbet-innovation-0 2025-08-14T15:01:53+02:00 0.5 http://www.guerbet.com/fr/actualites/resultats-annuels-2024 2025-07-17T09:18:27+02:00 0.5 http://www.guerbet.com/news/2024-full-year-results 2025-07-17T09:18:27+02:00 0.5 http://www.guerbet.com/fr/guerbet-remporte-le-trophee-rse-2021-des-entreprises-du-medicament 2021-12-03T16:45:23+01:00 0.5 http://www.guerbet.com/fr/carine-dagommer-est-nommee-administrateur-de-guerbet-renouvellement-du-mandat-de-nicolas-louvet 2022-05-25T06:59:55+02:00 0.5 http://www.guerbet.com/fr/resultats-annuels-2022 2023-12-22T12:44:49+01:00 0.5 http://www.guerbet.com/fr/chiffre-daffaires-du-1er-trimestre-2023 2023-12-22T12:42:25+01:00 0.5 http://www.guerbet.com/fr/evolution-du-conseil-dadministration-de-guerbet 2023-05-26T16:03:53+02:00 0.5 http://www.guerbet.com/fr/journee-mondiale-de-lenvironnement-guerbet-poursuit-son-engagement-pour-le-climat 2023-06-07T14:11:25+02:00 0.5 http://www.guerbet.com/fr/actualites/intrasense-rejoint-le-groupe-guerbet-pour-creer-un-acteur-majeur-de-lintelligence 2024-01-12T15:25:18+01:00 0.5 http://www.guerbet.com/fr/simafex-au-coeur-des-ambitions-guerbet-leader-de-limagerie-medical 2023-12-22T12:36:14+01:00 0.5 http://www.guerbet.com/fr/guerbet-salue-le-lancement-de-la-chaire-megadore-pour-un-avenir-plus-vert-dans-limagerie-medicale 2023-12-22T12:35:24+01:00 0.5 http://www.guerbet.com/fr/chiffre-daffaires-au-30-septembre-2023 2023-12-22T12:33:38+01:00 0.5 http://www.guerbet.com/fr/guerbet-annonce-lobtention-de-lautorisation-de-mise-sur-le-marche-deluciremtm-gadopiclenol-dans 2023-12-22T12:28:24+01:00 0.5 http://www.guerbet.com/fr/chiffre-daffaires-2023 2024-02-08T17:05:51+01:00 0.5 http://www.guerbet.com/fr/intrasense-et-guerbet-annoncent-la-certification-ce-de-myrian-212-enrichie-de-lia-prostate-de 2024-04-08T16:16:52+02:00 0.5 http://www.guerbet.com/fr/insights/guerbet-nomme-dans-le-linkedin-top-companies 2024-04-25T16:35:31+02:00 0.5 http://www.guerbet.com/fr/chiffre-daffaires-du-1er-trimestre-2024 2024-04-25T15:52:02+02:00 0.5 http://www.guerbet.com/fr/actualites/nuclidium-et-guerbet-concluent-un-partenariat-strategique-pour-soutenir-le-developpement 2024-05-22T15:59:47+02:00 0.5 http://www.guerbet.com/fr/actualites/hugues-lecat-nomme-president-du-conseil-dadministration-de-guerbet 2024-05-24T16:16:11+02:00 0.5 http://www.guerbet.com/fr/insights/guerbet-sur-la-chaine-dinformation-bfmbusiness 2024-05-30T10:11:47+02:00 0.5 http://www.guerbet.com/fr/insights/sur-le-chemin-des-achats-responsables 2024-06-05T16:44:18+02:00 0.5 http://www.guerbet.com/fr/chiffre-daffaires-du-1er-semestre-2024 2024-07-25T15:49:31+02:00 0.5 http://www.guerbet.com/fr/resultats-semestriels-2024 2024-09-25T15:51:43+02:00 0.5 http://www.guerbet.com/fr/gadopiclenol-commercialise-sous-le-nom-eluciremr-par-guerbet-recoit-le-prix-innovation-jfr-2024 2024-10-04T09:01:48+02:00 0.5 http://www.guerbet.com/fr/guerbet-intrasense-gustave-roussy-et-le-chu-dangers-obtiennent-un-financement-de-59-meu-de 2024-12-03T17:11:21+01:00 0.5 http://www.guerbet.com/fr/insights/election-de-philippe-bourrinet-lacademie-nationale-de-pharmacie 2024-12-20T12:25:08+01:00 0.5 http://www.guerbet.com/fr/linitiative-people-planet-techops-lhonneur-dans-le-rapport-pactes-du-leem 2025-01-16T15:24:14+01:00 0.5 http://www.guerbet.com/fr/la-us-food-and-drug-administration-fda-accorde-le-statut-de-breakthrough-device-linnovation-guerbet 2025-02-10T11:21:52+01:00 0.5 http://www.guerbet.com/fr/chiffre-daffaires-2024 2025-02-06T16:54:51+01:00 0.5 http://www.guerbet.com/fr/guerbet-sengage-dans-legalite-professionnelle 2026-02-27T11:26:45+01:00 0.5 http://www.guerbet.com/fr/actualites/chiffre-daffaires-du-1er-semestre-2025 2025-07-28T00:25:18+02:00 0.5 http://www.guerbet.com/news/h1-2025-revenue 2025-07-28T00:25:18+02:00 0.5 http://www.guerbet.com/news/q1-2025-revenue 2025-08-14T15:02:58+02:00 0.5 http://www.guerbet.com/h1-2025-revenue 2025-07-29T13:50:41+02:00 0.5 http://www.guerbet.com/guerbet-australia-announces-therapeutic-goods-administration-tga-approval-eluciremtm-gadopiclenol 2025-07-29T13:57:03+02:00 0.5 http://www.guerbet.com/news/changes-composition-guerbet-board-directors 2025-08-14T14:59:15+02:00 0.5 http://www.guerbet.com/fr/actualites/guerbet-annonce-lapprobation-par-la-therapeutic-goods-administration-tga-deluciremtm 2025-07-29T17:21:15+02:00 0.5 http://www.guerbet.com/fr/actualites/evolution-de-la-composition-du-conseil-dadministration-de-guerbet 2025-07-29T17:20:53+02:00 0.5 http://www.guerbet.com/fr/arthrose-embolisation-osteoarticulaire 2025-10-07T10:25:48+02:00 0.5 http://www.guerbet.com/osteoarthritis-osteoembolization 2025-10-07T10:25:48+02:00 0.5 http://www.guerbet.com/fr/actualites/ajustement-des-objectifs-financiers-2025 2025-09-15T17:58:08+02:00 0.5 http://www.guerbet.com/news/adjustment-2025-full-year-financial-targets 2025-09-15T17:58:08+02:00 0.5 http://www.guerbet.com/fr/actualites/evolution-de-la-direction-generale 2025-09-26T17:15:11+02:00 0.5 http://www.guerbet.com/news/change-general-management 2025-09-26T17:15:11+02:00 0.5 http://www.guerbet.com/news/h1-2025-results 2025-09-25T10:47:10+02:00 0.5 http://www.guerbet.com/fr/actualites/resultats-semestriels-2025 2025-09-24T18:08:13+02:00 0.5 http://www.guerbet.com/fr/actualites/chiffre-daffaires-au-30-septembre-2025 2025-10-23T17:57:48+02:00 0.5 http://www.guerbet.com/news/revenue-september-30-2025 2025-10-23T17:57:48+02:00 0.5 http://www.guerbet.com/fr/actualites/evolutions-au-sein-du-comite-executif 2025-11-04T17:33:17+01:00 0.5 http://www.guerbet.com/news/guerbet-french-healthcare 2025-11-24T15:06:06+01:00 0.5 http://www.guerbet.com/fr/actualites/guerbet-innovation-et-cooperation-francaise-lhonneur-au-rsna-2025 2025-11-24T15:17:53+01:00 0.5 http://www.guerbet.com/fr/actualites/calendrier-financier-de-lexercice-2026 2025-12-23T09:50:21+01:00 0.5 http://www.guerbet.com/news/financial-agenda-2026 2025-11-24T15:41:05+01:00 0.5 http://www.guerbet.com/news/chmp-grants-positive-opinion-eluciremtm-gadopiclenol-pediatric-indication-extension-under-two 2025-12-19T10:52:50+01:00 0.5 http://www.guerbet.com/fr/actualites/le-chmp-emet-un-avis-favorable-pour-eluciremtm-gadopiclenol-en-vue-dune-extension-de-son 2025-12-19T10:59:01+01:00 0.5 http://www.guerbet.com/news/guerbet-announces-appointment-mr-francois-convenant-senior-vice-president-interventional 2025-12-19T15:32:23+01:00 0.5 http://www.guerbet.com/fr/actualites/guerbet-annonce-la-nomination-de-m-francois-convenant-en-tant-que-senior-vice-president 2025-12-19T15:38:10+01:00 0.5 http://www.guerbet.com/news/new-indication-children-birth-guerbets-half-dose-gbca-eluciremtm-gadopiclenol-approved 2026-01-28T15:05:56+01:00 0.5 http://www.guerbet.com/fr/actualites/nouvelle-indication-des-la-naissance-pour-lagent-de-contraste-demi-dose-de-guerbet 2026-01-28T15:14:18+01:00 0.5 http://www.guerbet.com/news/karim-boussebaa-appointed-chief-executive-officer-guerbet 2026-01-28T17:53:43+01:00 0.5 http://www.guerbet.com/fr/actualites/karim-boussebaa-nomme-directeur-general-de-guerbet 2026-01-28T18:09:31+01:00 0.5 http://www.guerbet.com/news/2025-revenue 2026-02-05T17:49:28+01:00 0.5 http://www.guerbet.com/fr/actualites/chiffre-daffaires-2025 2026-02-05T17:47:10+01:00 0.5 http://www.guerbet.com/news/change-guerbets-board-directors-0 2026-03-11T17:52:19+01:00 0.5 http://www.guerbet.com/fr/actualites/evolution-du-conseil-dadministration-de-guerbet 2026-03-11T17:57:30+01:00 0.5 http://www.guerbet.com/fr/actualites/resultats-annuels-2025 2026-03-11T18:02:51+01:00 0.5 http://www.guerbet.com/news/2025-full-year-results 2026-03-11T17:49:14+01:00 0.5 http://www.guerbet.com/fr/actualites/chiffre-daffaires-du-1er-trimestre-2026 2026-04-23T17:54:08+02:00 0.5 http://www.guerbet.com/news/q1-2026-revenue 2026-04-23T17:49:39+02:00 0.5 http://www.guerbet.com/news/guerbet-announces-important-milestone-achievement-vascular-embolization-indication-lipiodolr 2026-04-24T12:16:07+02:00 0.5 http://www.guerbet.com/fr/actualites/guerbet-annonce-une-etape-majeure-dans-lindication-embolisation-vasculaire-pour 2026-04-24T12:15:32+02:00 0.5 http://www.guerbet.com/news/changes-composition-guerbets-board-directors 2026-05-22T18:39:15+02:00 0.5 http://www.guerbet.com/fr/actualites/evolution-de-la-composition-du-conseil-dadministration-de-guerbet-0 2026-05-22T18:37:22+02:00 0.5 http://www.guerbet.com/fr/investisseurs 2026-05-22T16:52:15+02:00 0.5 http://www.guerbet.com/investors 2026-05-22T16:52:15+02:00 0.5 http://www.guerbet.com/fr/investisseurs/chiffres-cles 2026-03-23T11:48:57+01:00 0.5 http://www.guerbet.com/investors/guerbet-key-figures 2026-03-23T11:48:57+01:00 0.5 http://www.guerbet.com/fr/investisseurs/laction-guerbet 2026-05-04T14:10:02+02:00 0.5 http://www.guerbet.com/investors/stock-performance 2026-05-04T14:10:02+02:00 0.5 http://www.guerbet.com/fr/politique-financiere 2024-07-15T15:30:21+02:00 0.5 http://www.guerbet.com/investors/financial-policy 2024-07-15T15:30:21+02:00 0.5 http://www.guerbet.com/fr/strategie 2024-07-15T15:30:29+02:00 0.5 http://www.guerbet.com/strategy 2024-07-15T15:30:29+02:00 0.5 http://www.guerbet.com/fr/notre-groupe/gouvernement-dentreprise 2026-05-22T18:24:54+02:00 0.5 http://www.guerbet.com/our-group/corporate-governance 2026-05-22T18:24:54+02:00 0.5 http://www.guerbet.com/fr/investisseurs/presentations-rapports-information-reglementee-v0 2026-04-03T12:49:30+02:00 0.5 http://www.guerbet.com/investors/presentations-reports-regulated-information 2026-04-03T12:49:30+02:00 0.5 http://www.guerbet.com/fr/agenda 2025-11-19T13:42:27+01:00 0.5 http://www.guerbet.com/investors/agenda 2025-11-19T13:42:27+01:00 0.5 http://www.guerbet.com/fr/investisseurs/assemblee-generale 2026-03-18T11:58:38+01:00 0.5 http://www.guerbet.com/investors/general-meetings 2026-03-18T11:58:38+01:00 0.5 http://www.guerbet.com/fr/notre-groupe/carrieres 2025-07-27T23:31:45+02:00 0.5 http://www.guerbet.com/our-group/careers 2025-07-27T23:31:45+02:00 0.5 http://www.guerbet.com/fr/ma-carriere 2020-01-22T14:12:28+01:00 0.5 http://www.guerbet.com/our-group/careers/my-career-path 2020-01-22T14:12:28+01:00 0.5 http://www.guerbet.com/fr/nos-metiers 2022-02-09T10:00:23+01:00 0.5 http://www.guerbet.com/our-group/careers/our-job-families 2022-02-09T10:00:23+01:00 0.5 http://www.guerbet.com/fr/pourquoi-nous-rejoindre 2024-02-16T10:07:35+01:00 0.5 http://www.guerbet.com/our-group/careers/reasons-join-us 2024-02-16T10:07:35+01:00 0.5 http://www.guerbet.com/fr/notre-groupe 2026-05-06T12:03:22+02:00 0.5 http://www.guerbet.com/our-group 2026-05-06T12:03:22+02:00 0.5 http://www.guerbet.com/fr/notre-groupe/guerbet-en-bref-2025 2025-07-16T17:25:43+02:00 0.5 http://www.guerbet.com/our-group/guerbet-nutshell 2025-07-16T17:25:43+02:00 0.5 http://www.guerbet.com/fr/guerbet-en-bref 2025-04-08T08:27:09+02:00 0.5 http://www.guerbet.com/organization 2025-04-08T08:27:09+02:00 0.5 http://www.guerbet.com/fr/groupe/notre-responsabilite 2026-05-07T12:03:33+02:00 0.5 http://www.guerbet.com/our-group/our-responsibility 2026-05-07T12:03:33+02:00 0.5 http://www.guerbet.com/fr/notre-histoire-et-notre-avenir 2026-05-05T15:59:46+02:00 0.5 http://www.guerbet.com/our-history-future-1 2026-05-05T15:59:46+02:00 0.5 http://www.guerbet.com/fr/innovations-rd 2025-04-08T16:54:42+02:00 0.5 http://www.guerbet.com/our-innovation 2025-04-08T16:54:42+02:00 0.5 http://www.guerbet.com/footer 2026-05-22T10:11:40+02:00 0.5 http://www.guerbet.com/media 2025-10-03T12:03:13+02:00 0.5 http://www.guerbet.com/en-be/news 2025-10-03T12:03:13+02:00 0.5 http://www.guerbet.com/fr/mentions-legales 2025-11-12T14:44:47+01:00 0.5 http://www.guerbet.com/legal-information 2025-11-12T14:44:47+01:00 0.5 http://www.guerbet.com/fr/brevets 2024-04-17T09:19:26+02:00 0.5 http://www.guerbet.com/patents 2024-04-17T09:19:26+02:00 0.5 http://www.guerbet.com/fr/contact 2026-05-27T17:08:19+02:00 0.5 http://www.guerbet.com/contact-us 2026-05-27T17:08:19+02:00 0.5 http://www.guerbet.com/search-results 2019-11-24T14:13:25+01:00 0.5 http://www.guerbet.com/ecr-2020 2021-03-15T15:11:49+01:00 0.5 http://www.guerbet.com/fr/assemblee-generale-2020 2020-06-02T12:45:23+02:00 0.5 http://www.guerbet.com/2020-general-meeting 2020-06-02T12:45:23+02:00 0.5 http://www.guerbet.com/fr/assemblee-generale-2019 2020-05-06T16:14:15+02:00 0.5 http://www.guerbet.com/2019-general-meeting 2020-05-06T16:14:15+02:00 0.5 http://www.guerbet.com/eshre-virtual-36th-annual-meeting 2021-05-17T17:08:55+02:00 0.5 http://www.guerbet.com/ecr-2020-contact-us 2021-02-10T09:12:59+01:00 0.5 http://www.guerbet.com/cirse-2020 2021-10-12T12:06:35+02:00 0.5 http://www.guerbet.com/cirse-2020-contact-us 2021-02-08T13:41:04+01:00 0.5 http://www.guerbet.com/eshre-2021 2021-08-30T07:41:24+02:00 0.5 http://www.guerbet.com/your-communication-preferences 2025-07-18T14:46:20+02:00 0.5 http://www.guerbet.com/connecting-patient-organizations 2021-02-05T11:17:33+01:00 0.5 http://www.guerbet.com/ecr-2021 2023-07-04T14:15:52+02:00 0.5 http://www.guerbet.com/ecr-2021-live-demos 2022-05-05T09:25:49+02:00 0.5 http://www.guerbet.com/ecr-2021-contact-us 2021-02-10T09:57:12+01:00 0.5 http://www.guerbet.com/ecio-2021 2022-02-22T10:08:53+01:00 0.5 http://www.guerbet.com/prefilled-syringes 2025-07-23T20:16:46+02:00 0.5 http://www.guerbet.com/ecio-2022-contact-us 2022-05-05T10:08:00+02:00 0.5 http://www.guerbet.com/fr/notre-raison-detre 2021-05-06T10:23:02+02:00 0.5 http://www.guerbet.com/our-purpose 2021-05-06T10:23:02+02:00 0.5 http://www.guerbet.com/fr/assemblee-generale-2021 2022-05-12T12:19:29+02:00 0.5 http://www.guerbet.com/2021-general-meeting 2022-05-12T12:19:29+02:00 0.5 http://www.guerbet.com/ecio-2021-educational-sessions-replay 2022-06-28T11:19:39+02:00 0.5 http://www.guerbet.com/fr/brochure-de-convocation-ag-2021 2021-05-05T16:02:42+02:00 0.5 http://www.guerbet.com/notice-meeting-brochure-2021 2021-05-05T16:02:42+02:00 0.5 http://www.guerbet.com/et-2021 2022-05-17T12:27:02+02:00 0.5 http://www.guerbet.com/et-2021-contact-us 2021-07-09T13:52:20+02:00 0.5 http://www.guerbet.com/et-2021-educational-sessions-replay 2022-03-01T15:43:17+01:00 0.5 http://www.guerbet.com/optirayr 2025-07-23T19:44:24+02:00 0.5 http://www.guerbet.com/xenetixr 2025-07-23T19:30:30+02:00 0.5 http://www.guerbet.com/fr/newsletter-investisseurs 2024-07-15T15:29:54+02:00 0.5 http://www.guerbet.com/investors-newsletter 2024-07-15T15:29:54+02:00 0.5 http://www.guerbet.com/register-our-upcoming-webinars 2021-09-16T12:25:38+02:00 0.5 http://www.guerbet.com/cirse-2021 2021-10-18T16:06:16+02:00 0.5 http://www.guerbet.com/cirse-2021-contact-us 2021-09-06T09:28:24+02:00 0.5 http://www.guerbet.com/pink-october 2025-07-23T18:58:51+02:00 0.5 http://www.guerbet.com/fr/guerbet-radiologie-events 2025-07-23T19:50:00+02:00 0.5 http://www.guerbet.com/guerbet-radiology-events 2025-07-23T19:50:00+02:00 0.5 http://www.guerbet.com/rsna21-outside-us-hcps 2022-07-04T08:27:53+02:00 0.5 http://www.guerbet.com/education-resources 2026-06-02T11:23:34+02:00 0.5 http://www.guerbet.com/hcc-management 2023-06-29T14:41:15+02:00 0.5 http://www.guerbet.com/how-guerbet-aims-improve-ai-therapeutic-management-patients-cholangiocarcinoma 2022-02-12T08:56:49+01:00 0.5 http://www.guerbet.com/contact-us-7 2022-04-11T09:34:05+02:00 0.5 http://www.guerbet.com/ecr-2022-symposium 2022-06-29T07:21:07+02:00 0.5 http://www.guerbet.com/ecio-2022 2022-07-07T14:56:12+02:00 0.5 http://www.guerbet.com/innovation-x-ray-and-iodinated-contrast-media 2022-09-05T13:36:21+02:00 0.5 http://www.guerbet.com/innovation-mri 2023-03-17T16:34:19+01:00 0.5 http://www.guerbet.com/embolization 2022-10-21T13:03:26+02:00 0.5 http://www.guerbet.com/fertility-and-womens-health 2022-04-21T07:29:36+02:00 0.5 http://www.guerbet.com/augmented-intelligence 2024-03-12T11:29:40+01:00 0.5 http://www.guerbet.com/lymphography-0 2022-10-21T13:08:16+02:00 0.5 http://www.guerbet.com/clinical-cases 2023-07-12T13:38:53+02:00 0.5 http://www.guerbet.com/fr/assemblee-generale-2022 2023-05-03T14:25:35+02:00 0.5 http://www.guerbet.com/2022-general-meeting 2023-05-03T14:25:35+02:00 0.5 http://www.guerbet.com/et-2022 2023-06-02T12:18:41+02:00 0.5 http://www.guerbet.com/et-2022-contact-us 2022-05-20T14:14:08+02:00 0.5 http://www.guerbet.com/eshre2022-contact-us 2022-09-21T09:36:56+02:00 0.5 http://www.guerbet.com/ecr-2022 2023-07-05T07:31:53+02:00 0.5 http://www.guerbet.com/cirse-2022 2022-09-28T08:55:35+02:00 0.5 http://www.guerbet.com/ecr-2022-diagnostic-imaging-brochures 2023-02-01T15:33:21+01:00 0.5 http://www.guerbet.com/cirse-2022-contact-us 2022-07-13T11:50:24+02:00 0.5 http://www.guerbet.com/icobrain-artificial-intelligence-solution 2022-09-13T07:30:09+02:00 0.5 http://www.guerbet.com/request-your-demo 2025-07-23T19:33:22+02:00 0.5 http://www.guerbet.com/ask-us 2025-07-23T19:41:06+02:00 0.5 http://www.guerbet.com/linkedin-learn-more 2025-07-23T19:58:10+02:00 0.5 http://www.guerbet.com/cookie-policy 2025-01-28T12:57:10+01:00 0.5 http://www.guerbet.com/ecr-2023 2023-07-04T14:16:33+02:00 0.5 http://www.guerbet.com/ecr-2023-diagnostic-imaging-brochures 2023-02-09T17:00:56+01:00 0.5 http://www.guerbet.com/access-icobrain-dm-e-learning-module 2025-07-23T19:36:27+02:00 0.5 http://www.guerbet.com/fr/assemblee-generale-2023 2023-05-30T09:42:31+02:00 0.5 http://www.guerbet.com/2023-general-meeting 2023-05-30T09:42:31+02:00 0.5 http://www.guerbet.com/et-2023 2023-06-28T09:21:49+02:00 0.5 http://www.guerbet.com/reveal-tv 2024-02-15T10:53:09+01:00 0.5 http://www.guerbet.com/reveal-tv-linkedin 2025-07-23T19:54:07+02:00 0.5 http://www.guerbet.com/ecr-2024 2025-01-14T16:02:00+01:00 0.5 http://www.guerbet.com/oncological-imaging-how-improve-detection-ai 2025-07-23T19:39:28+02:00 0.5 http://www.guerbet.com/oncological-imaging-how-improve-detection-ai-webinar 2025-07-23T19:55:06+02:00 0.5 http://www.guerbet.com/fr/assemblee-generale-2024 2024-05-27T10:00:44+02:00 0.5 http://www.guerbet.com/2024-general-meeting 2024-05-27T10:00:44+02:00 0.5 http://www.guerbet.com/ecr-2025 2025-02-24T15:24:52+01:00 0.5 http://www.guerbet.com/data-protection-policy 2025-07-17T11:07:25+02:00 0.5 http://www.guerbet.com/blue-november 2025-10-13T17:18:28+02:00 0.5 http://www.guerbet.com/liver-cancer-awareness-month 2025-07-29T08:26:18+02:00 0.5 http://www.guerbet.com/2025-general-meeting 2025-09-03T11:44:29+02:00 0.5 http://www.guerbet.com/fr/guerbet-et-le-paqtefr 2021-04-28T14:18:00+02:00 0.5 http://www.guerbet.com/fr/assemblee-generale-2018 2020-05-06T15:16:06+02:00 0.5 http://www.guerbet.com/fr/interview-resultats-annuels-2021-perspectives 2024-07-15T15:29:45+02:00 0.5 http://www.guerbet.com/fr/guerbet-sengage-dans-legalite-professionnelle-0 2025-03-12T13:29:43+01:00 0.5 http://www.guerbet.com/fr/modes-de-detention-des-actions-et-contacts 2024-07-15T15:30:02+02:00 0.5 http://www.guerbet.com/fr/semaine-de-lindustrie-2021 2021-11-18T08:28:03+01:00 0.5 http://www.guerbet.com/fr/politique-des-cookies 2022-12-22T13:34:22+01:00 0.5 http://www.guerbet.com/fr/assemblee-generale-2025 2025-09-03T11:43:54+02:00 0.5 http://www.guerbet.com/fr/page-daccueil 2026-05-22T17:54:20+02:00 0.5 http://www.guerbet.com/homepage 2026-05-22T17:54:20+02:00 0.5 http://www.guerbet.com/products-solutions 2025-07-20T19:18:43+02:00 0.5 http://www.guerbet.com/de-at/produkte-und-losungen 2025-07-20T19:18:43+02:00 0.5 http://www.guerbet.com/insights 2025-07-22T11:26:34+02:00 0.5 http://www.guerbet.com/en-be/insights 2025-07-22T11:26:34+02:00 0.5 http://www.guerbet.com/patient-resources 2025-10-03T17:42:32+02:00 0.5 http://www.guerbet.com/fr/filtered-news-list-test-fr 2025-07-24T14:30:30+02:00 0.5 http://www.guerbet.com/filtered-news-list-test 2025-07-24T14:30:30+02:00 0.5 http://www.guerbet.com/fr/notre-groupe/intrasense-filiale-du-groupe-guerbet-innover-en-ia-ensemble 2026-02-18T14:29:26+01:00 0.5 http://www.guerbet.com/our-group/intrasense-guerbet-group-subsidiary-innovating-ai-together 2026-02-18T14:29:26+01:00 0.5 http://www.guerbet.com/cirse-2025 2025-09-15T18:24:20+02:00 0.5 http://www.guerbet.com/fr/politique-de-protection-des-donnees 2025-08-19T16:21:42+02:00 0.5 http://www.guerbet.com/fr/presentations-rapports-information-reglementee 2025-09-25T12:40:27+02:00 0.5 http://www.guerbet.com/guerbet-ireland-gender-pay-gap-report 2025-12-15T16:24:06+01:00 0.5 http://www.guerbet.com/fr/guerbet-visiblement-different-depuis-100-ans 2026-06-03T09:30:10+02:00 0.5 http://www.guerbet.com/guerbet-visibly-different 2026-06-03T09:30:10+02:00 0.5 http://www.guerbet.com/new-indication-children-birth-guerbets-half-dose-gbca-eluciremtm-gadopiclenol-approved-european 2026-01-27T18:08:45+01:00 0.5 http://www.guerbet.com/fr/nouvelle-indication-des-la-naissance-pour-lagent-de-contraste-demi-dose-de-guerbet-eluciremtm 2026-01-27T18:00:07+01:00 0.5 http://www.guerbet.com/ecr-2026 2026-02-10T18:14:15+01:00 0.5 http://www.guerbet.com/2026-general-meeting 2026-05-22T18:31:49+02:00 0.5 http://www.guerbet.com/fr/assemblee-generale-2026 2026-05-22T18:31:20+02:00 0.5 http://www.guerbet.com/100-years 2026-04-01T14:26:10+02:00 0.5 http://www.guerbet.com/guerbet-saga 2026-05-07T09:20:31+02:00 0.5 http://www.guerbet.com/fr/la-saga-guerbet 2026-05-07T09:13:24+02:00 0.5 http://www.guerbet.com/fr/100-ans 2026-04-01T15:23:39+02:00 0.5 http://www.guerbet.com/fr/products-solutions/home-mri-innovations/dotaremr 2025-10-15T12:17:18+02:00 0.5 http://www.guerbet.com/products-solutions/home-mri-innovations/dotaremr 2025-10-15T12:17:18+02:00 0.5 http://www.guerbet.com/fr/products-solutions/home-mri-innovations/artiremr 2025-07-20T18:58:06+02:00 0.5 http://www.guerbet.com/products-solutions/home-mri-innovations/artiremr 2025-07-20T18:58:06+02:00 0.5 http://www.guerbet.com/fr/products-solutions/contrast-agents/xenetixr-scanbagr-par-xenetixr 2025-10-15T12:15:46+02:00 0.5 http://www.guerbet.com/products-solutions/contrast-agents/xenetixr-scanbagr-xenetixr 2025-10-15T12:15:46+02:00 0.5 http://www.guerbet.com/fr/products-solutions/contrast-agents/optirayr 2025-10-15T12:11:14+02:00 0.5 http://www.guerbet.com/products-solutions/contrast-agents/optirayr 2025-10-15T12:11:14+02:00 0.5 http://www.guerbet.com/fr/products-solutions/contrast-agents/telebrixr-gastro 2025-07-20T18:58:46+02:00 0.5 http://www.guerbet.com/products-solutions/contrast-agents/telebrixr-gastro 2025-07-20T18:58:46+02:00 0.5 http://www.guerbet.com/fr/products-solutions/contrast-agents/conrayr-cysto-conrayr 2025-07-21T16:11:24+02:00 0.5 http://www.guerbet.com/products-solutions/contrast-agents/conrayr-cysto-conrayr 2025-07-21T16:11:24+02:00 0.5 http://www.guerbet.com/fr/products-solutions/contrast-agents/micropaquer-microtrastr 2025-07-20T18:59:56+02:00 0.5 http://www.guerbet.com/products-solutions/contrast-agents/micropaquer-microtrastr 2025-07-20T18:59:56+02:00 0.5 http://www.guerbet.com/fr/products-solutions/digital-solutions/contrastcarer 2025-04-04T14:59:14+02:00 0.5 http://www.guerbet.com/products-solutions/digital-solutions/contrastcarer-injection-management-solution 2025-04-04T14:59:14+02:00 0.5 http://www.guerbet.com/fr/products-solutions/service-support/optiprotecttm-3s 2025-08-12T09:00:25+02:00 0.5 http://www.guerbet.com/products-solutions/service-support/optiprotecttm-3s 2025-08-12T09:00:25+02:00 0.5 http://www.guerbet.com/fr/products-solutions/solutions-interconnectees-pour-limagerie-diagnostique 2025-07-17T11:43:23+02:00 0.5 http://www.guerbet.com/products-solutions/unik-diagnostic-imaging-interconnected-solutions 2025-07-17T11:43:23+02:00 0.5 http://www.guerbet.com/fr/products-solutions/injecteurs-consommables-accessoires/optistarr-elite 2025-09-03T14:24:28+02:00 0.5 http://www.guerbet.com/products-solutions/injectors-accessories-consumables/optistarr-elite 2025-09-03T14:24:28+02:00 0.5 http://www.guerbet.com/fr/products-solutions/injectors-accessories-consumables/injecteur-flowsens-syringeless 2025-04-04T14:58:19+02:00 0.5 http://www.guerbet.com/products-solutions/injectors-accessories-consumables/flowsensr-syringeless 2025-04-04T14:58:19+02:00 0.5 http://www.guerbet.com/fr/products-solutions/pharmaceutical-drugs/lipiodolr-ultra-fluide 2025-09-02T11:19:24+02:00 0.5 http://www.guerbet.com/products-solutions/pharmaceutical-drugs/lipiodolr-ultra-fluid 2025-09-02T11:19:24+02:00 0.5 http://www.guerbet.com/fr/products-solutions/injecteurs-consommables-accessoires/optivantager-single-use 2025-08-13T11:00:03+02:00 0.5 http://www.guerbet.com/products-solutions/injectors-accessories-consumables/optivantagetm-single-use 2025-08-13T11:00:03+02:00 0.5 http://www.guerbet.com/fr/products-solutions/pharmaceutical-drugs/bleu-patente-v 2025-07-20T18:38:28+02:00 0.5 http://www.guerbet.com/products-solutions/pharmaceutical-drugs/patent-blue-v 2025-07-20T18:38:28+02:00 0.5 http://www.guerbet.com/fr/products-solutions/injecteurs-consommables-accessoires/accessoires-irm 2025-08-13T15:30:59+02:00 0.5 http://www.guerbet.com/products-solutions/injectors-accessories-consumables/mri-accessories 2025-08-13T15:30:59+02:00 0.5 http://www.guerbet.com/fr/products-solutions/injecteurs-consommables-accessoires/systeme-de-chauffage-de-produits-de 2025-08-13T15:29:51+02:00 0.5 http://www.guerbet.com/products-solutions/injectors-accessories-consumables/ready-box 2025-08-13T15:29:51+02:00 0.5 http://www.guerbet.com/fr/products-solutions/injecteurs-consommables-accessoires/optioner 2025-09-29T13:47:39+02:00 0.5 http://www.guerbet.com/products-solutions/injectors-accessories-consumables/optionetm 2025-09-29T13:47:39+02:00 0.5 http://www.guerbet.com/fr/products-solutions/injecteurs-consommables-accessoires/illumenar-neo 2025-08-11T11:46:47+02:00 0.5 http://www.guerbet.com/products-solutions/injectors-accessories-consumables/illumenar-neo 2025-08-11T11:46:47+02:00 0.5 http://www.guerbet.com/fr/products-solutions/sante-des-femmes 2025-10-03T17:37:55+02:00 0.5 http://www.guerbet.com/products-solutions/womens-health 2025-10-03T17:37:55+02:00 0.5 http://www.guerbet.com/fr/products-solutions/urology/systeme-dimagerie-digitale-hydra-visiontm 2025-08-22T11:16:25+02:00 0.5 http://www.guerbet.com/fr/products-solutions/urology/accessoires-et-consommables-durologie 2025-08-22T11:25:10+02:00 0.5 http://www.guerbet.com/fr/products-solutions/injecteurs-consommables-accessoires/optivantager-multi-use 2025-09-15T16:28:17+02:00 0.5 http://www.guerbet.com/products-solutions/injectors-accessories-consumables/optivantagetm-multi-use 2025-09-15T16:28:17+02:00 0.5 http://www.guerbet.com/products-solutions/service-support/guerbet-service-support-during-covid-19 2023-08-22T08:23:06+02:00 0.5 http://www.guerbet.com/fr/products-solutions/injecteurs-consommables-accessoires/consommables-pour-limagerie-diagnostique 2025-09-08T14:53:56+02:00 0.5 http://www.guerbet.com/products-solutions/injectors-accessories-consumables/consumables-diagnostic-imaging 2025-09-08T14:53:56+02:00 0.5 http://www.guerbet.com/fr/products-solutions/contrast-agents/xenetixr-scanbagr-par-xenetixr-1 2025-08-19T16:32:33+02:00 0.5 http://www.guerbet.com/products-solutions/contrast-agents/xenetixr-smpc 2025-08-19T16:32:33+02:00 0.5 http://www.guerbet.com/fr/products-solutions/contrast-agents/xenetixr-scanbagr-par-xenetixr-1-1 2026-03-04T09:48:39+01:00 0.5 http://www.guerbet.com/products-solutions/home-mri-innovations/optirayr-smpc 2026-03-04T09:48:39+01:00 0.5 http://www.guerbet.com/products-solutions/home-mri-innovations/dotaremr-smpc 2024-07-22T12:56:09+02:00 0.5 http://www.guerbet.com/fr/products-solutions/home-mri-innovations/xenetixr-scanbagr-par-xenetixr-1-1-1 2024-07-22T12:56:09+02:00 0.5 http://www.guerbet.com/products-solutions/home-mri-innovations/prefilled-syringes-legal-mentions 2024-07-22T12:56:09+02:00 0.5 http://www.guerbet.com/fr/products-solutions/digital-solutions/icobrain-solution-dintelligence-artificielle 2025-04-04T14:59:49+02:00 0.5 http://www.guerbet.com/products-solutions/digital-solutions/icobrain-dm 2025-04-04T14:59:49+02:00 0.5 http://www.guerbet.com/products-solutions/injectors-accessories-consumables/optibolusr 2025-09-03T11:33:57+02:00 0.5 http://www.guerbet.com/products-solutions/digital-solutions/how-read-and-use-icobrain-dm-report 2024-02-15T09:35:55+01:00 0.5 http://www.guerbet.com/products-solutions/digital-solutions/discover-icobrain 2023-09-12T09:15:01+02:00 0.5 http://www.guerbet.com/products-solutions/digital-solutions/how-read-and-use-icobrain-ms-report 2024-02-19T14:29:43+01:00 0.5 http://www.guerbet.com/fr/products-solutions/home-mri-innovations/eluciremtm-gadopiclenol 2025-07-29T12:43:13+02:00 0.5 http://www.guerbet.com/products-solutions/home-mri-innovations/eluciremtm-gadopiclenol 2025-07-29T12:43:13+02:00 0.5 http://www.guerbet.com/fr/products-solutions/medical-devices/qitexior 2025-07-20T18:39:20+02:00 0.5 http://www.guerbet.com/products-solutions/medical-devices/qitexior-0 2025-07-20T18:39:20+02:00 0.5 http://www.guerbet.com/fr/products-solutions/solutions-dimagerie-interventionnelle 2025-09-01T16:26:23+02:00 0.5 http://www.guerbet.com/products-solutions/interventional-imaging-solutions 2025-09-01T16:26:23+02:00 0.5